We are live on ! Find out more
AMED

Amedisys
AMED

Delisted

AMED was delisted on the 14th of August, 2025.

Back to rankings

285 hedge funds and large institutions have $3.51B invested in Amedisys in 2019 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 105 increasing their positions, 105 reducing their positions, and 75 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.44% more ownership

Funds ownership: 88.11% → 90.56% (+2.4%)

1% more capital invested

Capital invested by funds: $3.47B → $3.51B (+$44.8M)

0% more repeat investments, than reductions

Existing positions increased: 105 | Existing positions reduced: 105

10% less funds holding

Funds holding: 317 → 285 (-32)

35% less first-time investments, than exits

New positions opened: 49 | Existing positions closed: 75

48% less call options, than puts

Call options by funds: $15.7M | Put options by funds: $30.5M

Holders
285
Holders Change
-32
Holders Change %
-10.09%
% of All Funds
6.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
49
Increased
105
Reduced
105
Closed
75
Calls
$15.7M
Puts
$30.5M
Net Calls
-$14.8M
Net Calls Change
+$1.33M

Top Buyers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$119M
2
William Blair Investment Management
William Blair Investment Management
Illinois
+$106M
3
RP
Riverbridge Partners
Minnesota
+$78.7M
4
EAM
Eagle Asset Management
Florida
+$34.6M
5
N
Nuveen
North Carolina
+$29.6M

Top Sellers

1
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$88.9M
2
Citadel Advisors
Citadel Advisors
Florida
-$33.3M
3
Millennium Management
Millennium Management
New York
-$26.7M
4
Ameriprise
Ameriprise
Minnesota
-$25.9M
5
JIM
Jupiter Investment Management
United Kingdom
-$23.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
RJFSA
326
Raymond James Financial Services Advisors
Florida
– -$404K -3,281 Closed
DTL
327
Dynamic Technology Lab
Singapore
– -$403K -3,266 Closed
CANY
328
Caxton Associates (New York)
New York
– -$387K -3,143 Closed
QT
329
Quantamental Technologies
New York
– -$387K -3,143 Closed
RWA
330
Redhawk Wealth Advisors
Minnesota
– -$370K -3,000 Closed
BCM
331
BlueCrest Capital Management
Jersey
– -$364K -2,951 Closed
TI
332
Trexquant Investment
Connecticut
– -$362K -2,933 Closed
C
333
Cerebellum
California
– -$338K -2,746 Closed
GCA
334
Gideon Capital Advisors
New York
– -$328K -2,658 Closed
QIM
335
Quantitative Investment Management
Virginia
– -$308K -2,500 Closed
CP
336
Camelot Portfolios
Ohio
– -$302K -2,450 Closed
Neuberger Berman Group
337
Neuberger Berman Group
New York
– -$298K -2,421 Closed
BCM
338
BBT Capital Management
Texas
– -$295K -2,396 Closed
FAM
339
Flaharty Asset Management
Florida
– -$279K -2,265 Closed
SAM
340
Sawgrass Asset Management
Florida
– -$274K -2,225 Closed
NL
341
NKCFO LLC
Illinois
– -$271K -2,200 Closed
N
342
Natixis
France
– -$255K -2,124 Closed
ACM
343
AlphaCrest Capital Management
New York
– -$248K -2,010 Closed
BC
344
Brinker Capital
Pennsylvania
– -$229K -1,857 Closed
IA
345
IFG Advisory
Georgia
– -$220K -1,790 Closed
GAM
346
GQ Asset Management
New York
– -$109K -885 Closed
CAM
347
Cresset Asset Management
Illinois
– -$103K -832 Closed
MA
348
MUFG Americas
New York
– -$40K -324 Closed
RFC
349
Regions Financial Corp
Alabama
– -$25K -200 Closed
Rockefeller Capital Management
350
Rockefeller Capital Management
New York
– -$16K -130 Closed
11 12 13
14
15

AMED Hedge Fund Activity: Q2 2019 in Review

285 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q2 2019, worth a combined $3.51B — up 1.3% from $3.47B a quarter earlier.

Sellers outnumbered buyers: 75 funds closed out of AMED and 49 opened new positions — a net loss of 26 holders — while 105 trimmed existing stakes and 105 added.

The largest buyer was T. Rowe Price Associates, adding an estimated $119M. The largest seller was Acadian Asset Management, exiting entirely with an estimated $88.9M sold.

  • 285 institutional investors held Amedisys (AMED) as of Q2 2019, down from 317 in Q1 2019.
  • Funds reported $3.51B of Amedisys stock for Q2 2019, up 1.3% quarter-over-quarter.
  • 49 funds opened new Amedisys positions in Q2 2019 and 75 closed out, a net change of -26 holders.
  • The largest Amedisys buyer in Q2 2019 was T. Rowe Price Associates, an estimated $119M added.
  • The largest Amedisys seller in Q2 2019 was Acadian Asset Management, an estimated $88.9M sold.

Based on aggregated 13F filings for Q2 2019.